Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia

British Journal of Haematology

Volumn 166, Issue 1, 2014, Pages 142-145

  Jayakody Arachchillage, Deepa ^a   Hurst, Erin ^b   Carey, Peter ^b   Moses, Samuel ^b   O'Brien, Stephen G ^b,c   Menne, Tobias ^b   Keenan, Fiona ^d   Wallis, Jonathan P ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

^d Department of Occupational Health and Wellbeing   (United Kingdom)

Author keywords

Chronic lymphocytic leukaemia; Fludarabine; Haemophagocytic lymphohistiocytosis

Indexed keywords

ALEMTUZUMAB; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BENDAMUSTINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DEXAMETHASONE; ETOPOSIDE; FERRITIN; FLUDARABINE; FOSCARNET; IMMUNOGLOBULIN G; RITUXIMAB; VALGANCICLOVIR;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CAUSE OF DEATH; CD4+ T LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CLOSTRIDIUM DIFFICILE INFECTION; COMPUTER ASSISTED TOMOGRAPHY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DISEASE COURSE; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; FEVER; HELPER CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOPHAGOCYTIC SYNDROME; HERPES SIMPLEX VIRUS; HERPES VIRUS INFECTION; HUMAN; HUMAN HERPESVIRUS 6; HUMAN PARVOVIRUS B19; HUMAN TISSUE; LYMPHADENOPATHY; MALE; MIDDLE AGED; MORTALITY; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; NEUTROPENIA; PANCYTOPENIA; PARVOVIRUS INFECTION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PURE RED CELL ANEMIA; SINGLE DRUG DOSE; SPLENOMEGALY; TREATMENT OUTCOME; VERY ELDERLY; VIRAL CLEARANCE;

CHRONIC LYMPHOCYTIC LEUKAEMIA; FLUDARABINE; HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MALE; MIDDLE AGED; VIDARABINE;

EID: 84902338091     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12822     Document Type: Article

References (10)

1. Arachchillage, D.R., Carr, T.F., Kerr, B., Hawkins, K., Kelsey, A., Judge, M. & Wynn, R.F. (2010) Juvenile myelomonocytic leukemia presenting with features of neonatal hemophagocytic lymphohistiocytosis and cutaneous juvenile xanthogranulomata and successfully treated with allogeneic hemopoietic stem cell transplant. Journal of Pediatric Hematology/oncology, 32, 152-155.
2. Balamuth, N.J., Nichols, K.E., Paessler, M. & Teachey, D.T. (2007) Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. Journal of Pediatric Hematology/oncology, 29, 569-573.
3. Boldt, D.H., Von Hoff, D.D., Kuhn, J.G. & Hersh, M. (1984) Effects on human peripheral lymphocytes of in vivo administration of 9-beta-D-arabinofuranosyl-2-fluoroadenine-5'-monophosphate (NSC 312887), a new purine antimetabolite. Cancer Research, 44, 4661-4666.
4. Hamblin, A.D. & Hamblin, T.J. (2008) The immunodeficiency of chronic lymphocytic leukaemia. British Medical Bulletin, 87, 49-62.
5. Henter, J.I., Horne, A., Arico, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J. & Janka, G. (2007) HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131.
6. Lazzarino, M., Orlandi, E., Baldanti, F., Furione, M., Pagnucco, G., Astori, C., Arcaini, L., Viglio, A., Paulli, M., Gerna, G. & Bernasconi, C. (1999) The immunosuppression and potential for EBV reactivation of fludarabine combined with cyclophosphamide and dexamethasone in patients with lymphoproliferative disorders. British Journal of Haematology, 107, 877-882.
7. Maakaroun, N.R., Moanna, A., Jacob, J.T. & Albrecht, H. (2010) Viral infections associated with haemophagocytic syndrome. Reviews in Medical Virology, 20, 93-105.
8. Meki, A., O'Connor, D., Roberts, C. & Murray, J. (2011) Hemophagocytic lymphohistiocytosis in chronic lymphocytic leukemia. Journal of Clinical Oncology, 29, e685-e687.
9. Speckmann, C., Pannicke, U., Wiech, E., Schwarz, K., Fisch, P., Friedrich, W., Niehues, T., Gilmour, K., Buiting, K., Schlesier, M., Eibel, H., Rohr, J., Superti-Furga, A., Gross-Wieltsch, U. & Ehl, S. (2008) Clinical and immunologic consequences of a somatic reversion in a patient with X-linked severe combined immunodeficiency. Blood, 112, 4090-4097.
10. Strout, M.P., Seropian, S. & Berliner, N. (2010) Alemtuzumab as a bridge to allogeneic SCT in atypical hemophagocytic lymphohistiocytosis. Nature Reviews Clinical Oncology, 7, 415-420.